{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:59:07Z","timestamp":1787162347464,"version":"build-2736575974"},"reference-count":19,"publisher":"Medical Association of Nippon Medical School","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1272\/jnms.83.118","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T18:36:23Z","timestamp":1468348583000},"page":"118-124","source":"Crossref","is-referenced-by-count":24,"title":["Neutrophil\/Lymphocyte Ratio in Patients with Rheumatoid Arthritis Treated with Biological Agents"],"prefix":"10.1272","volume":"83","author":[{"given":"Masahito","family":"Koiwa","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Nippon Medical School"},{"name":"Department of Orthopaedic Surgery, Shuuwa General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Shuuwa General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikazu","family":"Kamada","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Nippon Medical School"},{"name":"Hara Orthopedic Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinro","family":"Takai","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Nippon Medical School"},{"name":"Department of Orthopedics, Sanno Hospital\/International University of Health and Welfare"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL: Modified disease activity scores that include twenty-eight-joint count. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-48.","DOI":"10.1002\/art.1780380107"},{"key":"2","unstructured":"2. Aletaha D, Smolen J: The Simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005; 23(Suppl 39): S100-108."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kiely PD, Deighton C, Dixey J, Ost\u00f6r AJ; British Society for Rheumatology Standards, Guidelines and Audit Working Group: Biologic agents for rheumatoid arthritis-negotiating the NICE technology appraisals. Rheumatology (Oxford) 2012; 51: 24-31.","DOI":"10.1093\/rheumatology\/ker321"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Paramanathan A, Saxena A, Morris DL: A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg Oncol 2014; 23: 31-39.","DOI":"10.1016\/j.suronc.2013.12.001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ: The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 2013; 88: 218-230.","DOI":"10.1016\/j.critrevonc.2013.03.010"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Terashima T, Yamashita T, Iida N, Yamashita T, Nakagawa H, Arai K, Kitamura K, Kagaya T, Sakai Y, Mizukoshi E, Honda M, Kaneko S: Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy. Hepatol Res 2014; doi: 10.1111\/hepr.12436.","DOI":"10.1111\/hepr.12436"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cannon NA, Meyer J, Iyengar P, Ahn C, Westover KD, Choy H, Timmerman R: Neutrophil-lymphocyte and platelet-lymphocyte ratio as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer. J Thorac Oncol 2015; 10: 280-285.","DOI":"10.1097\/JTO.0000000000000399"},{"key":"8","unstructured":"8. Balli M, Ta\u015folar H, \u00c7etin M, Tekin K, \u00c7a\u011fliyan \u00c7E, T\u00fcrkmen S, Yilmaz M, Elbasan Z, \u015eahin DY, \u00c7ayli M: Use of the neutrophil to lymphocyte ratio for prediction of in-stent restenosis in bifurcation lesions. Eur Rev Med Pharmacol Sci 2015; 19: 1866-1873."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ha KS, Lee J, Jang GY, Lee J, Lee KC, Son CS, Lee JW: Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease. Am J Cardiol 2015; 116: 301-306.","DOI":"10.1016\/j.amjcard.2015.04.021"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lowsby R, Gomes C, Jarman I, Lisboa P, Nee PA, Vardhan M, Eckersley T, Saleh R, Mills H: Neutrophil to lymphocyte count ratio as an early indicator of blood stream infection in the emergency department. Emerg Med J 2015; 32: 531-534.","DOI":"10.1136\/emermed-2014-204071"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Farah R, Khamisy-Farah R: Association of neutrophil to lymphocyte ratio with presence and severity of gastritis due to Helicobacter pylori infection. J Clin Lab Anal 2014; 28: 219-223.","DOI":"10.1002\/jcla.21669"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Uslu AU, K\u00fc\u00e7\u00fck A, \u015eahin A, Ugan Y, Y\u0131lmaz R, G\u00fcng\u00f6r T, Ba\u011fcac\u0131 S, K\u00fc\u00e7\u00fck\u015fen S: Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Int J Rheum Dis 2015; 18: 731-735.","DOI":"10.1111\/1756-185X.12582"},{"key":"13","unstructured":"13. Fransen J, van Riel PL: The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005; 23: S93-99."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Symmons DP, Farr M, Salmon M, Bacon PA: Lymphopenia in rheumatoid arthritis. J R Soc Med 1989; 82: 462-463.","DOI":"10.1177\/014107688908200806"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hirashima M, Higuchi S, Sakamoto K, Nishiyama T, Okada H: The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol 1998; 124: 329-334.","DOI":"10.1007\/s004320050178"},{"key":"16","unstructured":"16. Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K: Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1\/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol 1999; 26: 251-258."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Takeuchi T, Miyasaka N, Tatsuki Y, Yano T, Yoshinari T, Abe T, Koike T: Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis. Ann Rheum Dis 2011; 70: 1208-1215.","DOI":"10.1136\/ard.2011.153023"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chen DY, Chen YM, Chen HH, Hsieh CW, Lin CC, Lan JL: Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-\u03b1 therapy. Arthritis Res Ther 2011; 13: R126.","DOI":"10.1186\/ar3431"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kayakabe K, Kuroiwa T, Sakurai N, Ikeuchi H, Kadiombo AT, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y: Interleukin-1\u03b2 measurement in stimulated whole blood cultures is useful to predict response to anti-TNF therapies in rheumatoid arthritis. Rheumatology (Oxford) 2012; 51: 1639-1643.","DOI":"10.1093\/rheumatology\/kes094"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/83\/3\/83_118\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T22:25:23Z","timestamp":1568154323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/83\/3\/83_118\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.83.118","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}